Key statistics dashboard for Cardio Diagnostics Holdings, Inc. (CDIO). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was established in 2017.
Stock Data
| Price | $2.00 |
| Market Cap | $6M |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -0.68 |
| Price / Book | 0.80 |
| P/S | 409.62 |
| P/FCF | -1.01 |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | -555.03% |
| EBIT Margin | -44686.72% |
| EBITDA Margin | -42721.94% |
| Operating Margin | -44690.68% |
| Net Margin | -44771.83% |
Financial Health
| Current Ratio | 17.15 |
| Quick Ratio | 17.15 |
| Cash Ratio | 15.55 |
| Debt / Equity | 0.05 |
| Debt / Assets | 4.66% |
| Interest Coverage | -525.07 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -3.61 |
Per-Share Data
| Revenue per share | 0.00 |
| Book Value per share | 2.51 |
| Cash per share | 1.89 |
| FCF per share | -1.97 |
| Tangible Book Value per share | 2.18 |
| Dividend per share | 0.00 |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 1 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 1 |
| Avg rating (1-5) | 1.00 |
Related companies: ADIL · ADXN · BCDA · BCLI · CELZ · IBO · MTNB
Explore sector: Healthcare · Biotechnology
More sections of CDIO: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks